Dr. Schmidt will deliver a talk at the National Academies on Tuesday, September 10th, 2024. The event is part of a one-day public workshop organized by a planning committee from the National Academies of Sciences, Engineering, and Medicine. This workshop will gather leaders and experts from academia, industry, government, philanthropic foundations, and disease-focused non-profit organizations. The focus will be on exploring potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in treating central nervous system disorders, including dementia, Parkinson’s disease, substance and alcohol use disorders, and pain.

Click here to learn more information: https://www.nationalacademies.org/event/43073_09-2024_examining-glucagon-like-peptide-1-receptor-glp-1r-agonists-for-central-nervous-system-disorders-a-workshop